These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19). Karimi-Galougahi M; Arastou S; Haseli S Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565 [No Abstract] [Full Text] [Related]
25. Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure. Menezes S; Kumar JS; Rudra OS; Nagral A BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35140094 [TBL] [Abstract][Full Text] [Related]
26. Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis. Kaur H; Kanaujia R; Rudramurthy SM Indian J Med Microbiol; 2021; 39(4):473-474. PubMed ID: 34266698 [No Abstract] [Full Text] [Related]
27. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit. Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110 [TBL] [Abstract][Full Text] [Related]
28. Initial and ongoing challenges with COVID-19-associated mucormycosis. Sikka K; Goel G; Sharma N; Thakar A Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965 [No Abstract] [Full Text] [Related]
29. Mucormycosis in COVID-19 recovered patients. Kumar A J Med Virol; 2022 Apr; 94(4):1272-1273. PubMed ID: 34905224 [No Abstract] [Full Text] [Related]
30. Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times. Singh AK; Singh R Indian J Ophthalmol; 2021 Sep; 69(9):2552. PubMed ID: 34427273 [No Abstract] [Full Text] [Related]
32. Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times. Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD Indian J Ophthalmol; 2021 Sep; 69(9):2553. PubMed ID: 34427274 [No Abstract] [Full Text] [Related]
33. Commentary: COVID-19-associated mucormycosis: The ongoing battle. Nair AG Indian J Ophthalmol; 2021 Dec; 69(12):3683-3684. PubMed ID: 34827022 [No Abstract] [Full Text] [Related]
34. Response to: COVID-19-associated mucormycosis and evolving evidence. Sarda R; Swain S; Ray A; Wig N QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346 [No Abstract] [Full Text] [Related]
35. Mucormycosis - An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19. Chavda VP; Apostolopoulos V Maturitas; 2021 Dec; 154():58-61. PubMed ID: 34364730 [No Abstract] [Full Text] [Related]
36. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic. Kamrul-Hasan AB; Selim S Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483 [TBL] [Abstract][Full Text] [Related]
37. Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess? Nair AG Indian J Ophthalmol; 2022 Mar; 70(3):1024-1025. PubMed ID: 35225565 [No Abstract] [Full Text] [Related]
38. Mucormycosis-Related Vision Loss in COVID-19. Dhoot SK Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):173-174. PubMed ID: 35272556 [No Abstract] [Full Text] [Related]
39. Mucormycosis: time to address this deadly fungal infection. Stone N; Gupta N; Schwartz I Lancet Microbe; 2021 Aug; 2(8):e343-e344. PubMed ID: 35544192 [No Abstract] [Full Text] [Related]
40. COVID-19-associated mucormycosis-elucidating the etiology of this emerging entity. Sakthivel P; Ish P QJM; 2022 Jun; 115(6):421. PubMed ID: 34264350 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]